Log in

RegulatoryCNBC-TV18

Aurobindo Pharma's Apitoria unit gets 'voluntary action indicated' classification from USFDA

Negative-33

GreyOak summary

Aurobindo Pharma's Apitoria unit received a Voluntary Action Indicated classification from the US FDA following an inspection of its API facility in Andhra Pradesh. The FDA identified three observations requiring voluntary address but closed the inspection without immediate regulatory action.

What it affects

Source

Reported by CNBC-TV18

More Aurobindo Pharma news

All Aurobindo Pharma news →

The company today

Price, day change, sector and market cap of the companies this story names
CompanyPriceDay changeSectorMarket cap
Aurobindo PharmaAUROPHARMA · NSE₹1,799.00−0.37%Healthcare₹1.04 lakh crore

Prices as of ; the last session's close when the market is shut. Research, not investment advice.

Latest market news

News Intelligence →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy